Though it follows a similar mechanism as GHK-Cu by signaling copper, its skin-specific benefits remain an area where additional research is developing
Products are lyophilized in powder form
They show meaningful potential, but theyre still considered supportive rather than foundational in an anti-aging routine. And while theres enough clinical evidence to validate the effectiveness of copper peptides in dermatology, there is a gap in the current research
It is manufactured by Novo Nordisk, the pharmaceutical company behind a recent trial assessing the potential of a next-generation drug, CagriSema
In glaucoma studies such as in in other eye disturbances studies (i.e., retinal ischemia), BPC 157 therapy may instantly break a noxious chain of events, both at its early stage and at an already advanced stage [11,12,13,14,15,16,17]